BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37876624)

  • 1. Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study.
    Cordova VHS; Teixeira AD; Anzolin AP; Moschetta R; Belmonte-de-Abreu PS
    Front Psychiatry; 2023; 14():1269322. PubMed ID: 37876624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-to-Lymphocyte Ratio Is Independently Associated With Severe Psychopathology in Schizophrenia and Is Changed by Antipsychotic Administration: A Large-Scale Cross-Sectional Retrospective Study.
    Zhou X; Wang X; Li R; Yan J; Xiao Y; Li W; Shen H
    Front Psychiatry; 2020; 11():581061. PubMed ID: 33192726
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
    Yıldız M; Osman E
    Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Inflammatory Biomarkers in Patients with Schizophrenia: A 3-Year Retrospective Study.
    Zhu X; Li R; Zhu Y; Zhou J; Huang J; Zhou Y; Tong J; Zhang P; Luo X; Chen S; Li Y; Tian B; Tan SP; Wang Z; Han X; Tian L; Li CR; Tan YL
    Neuropsychiatr Dis Treat; 2023; 19():1597-1604. PubMed ID: 37465565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Simple Markers of Inflammation and Systemic Immune Inflammation Index in Schizophrenia, Bipolar Disorder Patients and Healthy Controls.
    Inaltekin A; Yağci İ
    Turk Psikiyatri Derg; 2023; 34(1):11-15. PubMed ID: 36970957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Cell Count Ratios at Baseline are Associated with Initial Clinical Response to Clozapine in Treatment-Resistant, Clozapine-Naïve, Schizophrenia-Spectrum Disorder.
    Llorca-Bofí V; Bioque M; Madero S; Mallorquí A; Oliveira C; Garriga M; Parellada E; García-Rizo C
    Pharmacopsychiatry; 2024 Apr; ():. PubMed ID: 38621701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical predictors of response to clozapine treatment in ambulatory patients with schizophrenia.
    Umbricht DS; Wirshing WC; Wirshing DA; McMeniman M; Schooler NR; Marder SR; Kane JM
    J Clin Psychiatry; 2002 May; 63(5):420-4. PubMed ID: 12019667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Associations of Neutrophil-Lymphocyte, Platelet-Lymphocyte, Monocyte-Lymphocyte Ratios and Immune-Inflammation Index with Negative Symptoms in Patients with Schizophrenia.
    Šagud M; Madžarac Z; Nedic Erjavec G; Šimunović Filipčić I; Mikulić FL; Rogić D; Bradaš Z; Bajs Janović M; Pivac N
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Neutrophil-Lymphocyte Ratio Is Positively Correlated with Aggression in Schizophrenia.
    Tong Z; Zhu J; Wang JJ; Yang YJ; Hu W
    Biomed Res Int; 2022; 2022():4040974. PubMed ID: 35502339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine in treatment-resistant patients with schizophrenia, schizoaffective disorder, or psychotic bipolar disorder: a naturalistic 48-month follow-up study.
    Ciapparelli A; Dell'Osso L; Bandettini di Poggio A; Carmassi C; Cecconi D; Fenzi M; Chiavacci MC; Bottai M; Ramacciotti CE; Cassano GB
    J Clin Psychiatry; 2003 Apr; 64(4):451-8. PubMed ID: 12716249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial.
    Chang JS; Ahn YM; Park HJ; Lee KY; Kim SH; Kang UG; Kim YS
    J Clin Psychiatry; 2008 May; 69(5):720-31. PubMed ID: 18370574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
    Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The values of systemic immune-inflammation index and neutrophil-lymphocyte ratio in predicting testicular germ cell tumors: A retrospective clinical study.
    Wang S; Yang X; Yu Z; Du P; Cao Y; Ji Y; Ma J; Yang Y
    Front Oncol; 2022; 12():893877. PubMed ID: 36185298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
    Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
    Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical predictors of response to clozapine in Tunisian patients with treatment resistant schizophrenia.
    Aissa A; Jouini R; Ouali U; Zgueb Y; Nacef F; El Hechmi Z
    Compr Psychiatry; 2022 Jan; 112():152280. PubMed ID: 34763293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of clinical outcome in schizophrenic patients responding to clozapine.
    Mauri MC; Volonteri LS; Dell'Osso B; Regispani F; Papa P; Baldi M; Bareggi SR
    J Clin Psychopharmacol; 2003 Dec; 23(6):660-4. PubMed ID: 14624196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between clinical improvement and functional gains with clozapine in schizophrenia.
    Lee J; Takeuchi H; Fervaha G; Bhaloo A; Powell V; Remington G
    Eur Neuropsychopharmacol; 2014 Oct; 24(10):1622-9. PubMed ID: 25156578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
    Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
    Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome definitions and clinical predictors influence pharmacogenetic associations between HTR3A gene polymorphisms and response to clozapine in patients with schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Srivastava A; Jacob M; Jacob KS
    Psychopharmacology (Berl); 2012 Dec; 224(3):441-9. PubMed ID: 22700043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.